IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharmaceuticals: Nycomed to Shift European API Production to India

5:23 AM MDT | March 17, 2008 | Ed Berrigan

Pharmaceuticals firm Nycomed (Zurich, Switzerland) says it plans to transfer its current API production from facilities at Linz (Austria) and Singen (Germany) to Zydus Nycomed (Mumbai, India) in the next three-to-four years. Zydus Cadila (Ahmedabad, India) says that Zydus Nycomed its joint venture company with Nycomed will now become an active pharma ingredient (API) manufacturing hub. A letter of agreement has been signed between the two companies to amend their existing joint venture agreement to include the chemical production of APIs and this new development...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa